Cencora (COR) Stock: Buy, Sell, or Hold?
COR - Cencora, Inc.
$307.60
-2.18 (-0.70%)
▼
5d:
+0.22%
30d:
-8.55%
90d:
+3.03%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When COR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: COR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: COR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$467.94
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$290.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: COR is currently trading at $307.60, which is considered slightly low relative to its 30-day fair value range of $309.73 to $328.86. The stock's valuation (Forward PE: 15.6) is in line with its historical norms (16.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This pessimistic expectation contrasts with the company's recent 11.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, COR is in a strong uptrend. Immediate support is located at $295.01, while resistance sits at $320.24.
Market Sentiment: COR scores 87/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $369.25 (+19.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, COR is in a strong uptrend. Immediate support is located at $295.01, while resistance sits at $320.24.
Market Sentiment: COR scores 87/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $369.25 (+19.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$309.73 -
$328.86
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
88.1%
Protect Your Profits
Holding COR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (87/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($369.25)
- CAUTION: Bottoming setup, but lagging the sector by 22% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$309.73 -
$328.86
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$295.01
Resistance Level
$320.24
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.62
Wall Street Target
$369.25
(+19.2%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
11.9%
Profit Margin
0.8%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
15.6 vs 16.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$304.20
(-2%)
2-Year Target
$298.73
(-4%)
3-Year Target
$293.35
(-5%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$309.78
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 10.9%)
$551.63
(+78%)
Base:
(SPY PE: 15.6, Growth: 10.9%)
$422.51
(+36%)
Bear:
(PE: 13.3, Growth: 10.9%)
$359.13
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 22.29 | Current EPS (TTM): $13.47
Bull Case
$486.12
(+57%)
Analyst growth 47.2%, PE expands to 24.5
Base Case
$441.93
(+43%)
Market implied 47.2%, PE stable at 22.3
Bear Case
$204.17
(-34%)
Severe decline -20.0%, PE contracts to 19.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.6 to 16.5
Stabilization Target:
$327.13
(+5.6%)
PE Expansion Potential:
+5.6%
Share & Embed Analysis
Last updated: October 02, 2026 2:36 PM ET
Data refreshes hourly during market hours. Next update: 3:36 PM
Data refreshes hourly during market hours. Next update: 3:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$979 | 64 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$270 | 70 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$97 | 56 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 46 HOLD |
Advanced COR Option Strategies
Professional options setups generated by AI based on today's COR price and gamma walls.
